MX9707009A - Inyeccion de una vez al mes como un contraceptivo de base y para terapia de reemplazamiento hormonal para mujeres perimenopausicas y premenopausicas. - Google Patents
Inyeccion de una vez al mes como un contraceptivo de base y para terapia de reemplazamiento hormonal para mujeres perimenopausicas y premenopausicas.Info
- Publication number
- MX9707009A MX9707009A MX9707009A MX9707009A MX9707009A MX 9707009 A MX9707009 A MX 9707009A MX 9707009 A MX9707009 A MX 9707009A MX 9707009 A MX9707009 A MX 9707009A MX 9707009 A MX9707009 A MX 9707009A
- Authority
- MX
- Mexico
- Prior art keywords
- perimenopausal
- injectable
- month
- once
- useful
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19510861A DE19510861A1 (de) | 1995-03-16 | 1995-03-16 | Einmonatsspritze als Depot-Kontrazeptivum und für die Hormonersatztherapie für peri- und praemenopausale Frauen |
| PCT/EP1996/001201 WO1996028165A1 (de) | 1995-03-16 | 1996-03-15 | Einmonatsspritze als depot-kontrazeptivum und für die hormonersatztherapie für peri- und praemenopausale frauen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9707009A true MX9707009A (es) | 1997-11-29 |
Family
ID=7757668
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9707009A MX9707009A (es) | 1995-03-16 | 1996-03-15 | Inyeccion de una vez al mes como un contraceptivo de base y para terapia de reemplazamiento hormonal para mujeres perimenopausicas y premenopausicas. |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0814811A1 (ko) |
| JP (1) | JPH11501649A (ko) |
| KR (1) | KR19980703058A (ko) |
| AR (1) | AR002283A1 (ko) |
| AU (1) | AU713258B2 (ko) |
| CA (1) | CA2215382A1 (ko) |
| CZ (1) | CZ289697A3 (ko) |
| DE (1) | DE19510861A1 (ko) |
| HU (1) | HUP9801691A3 (ko) |
| IL (1) | IL117516A (ko) |
| MX (1) | MX9707009A (ko) |
| NO (1) | NO974255L (ko) |
| NZ (1) | NZ304027A (ko) |
| PL (1) | PL322202A1 (ko) |
| SK (1) | SK123997A3 (ko) |
| WO (1) | WO1996028165A1 (ko) |
| ZA (1) | ZA962177B (ko) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0000313D0 (en) | 2000-01-10 | 2000-03-01 | Astrazeneca Uk Ltd | Formulation |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4826831A (en) * | 1983-08-05 | 1989-05-02 | Pre Jay Holdings Limited | Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens |
-
1995
- 1995-03-16 DE DE19510861A patent/DE19510861A1/de not_active Withdrawn
-
1996
- 1996-03-15 AU AU51108/96A patent/AU713258B2/en not_active Ceased
- 1996-03-15 EP EP96907506A patent/EP0814811A1/de not_active Withdrawn
- 1996-03-15 AR ARP960101766A patent/AR002283A1/es unknown
- 1996-03-15 WO PCT/EP1996/001201 patent/WO1996028165A1/de not_active Application Discontinuation
- 1996-03-15 KR KR1019970706467A patent/KR19980703058A/ko not_active Application Discontinuation
- 1996-03-15 MX MX9707009A patent/MX9707009A/es not_active IP Right Cessation
- 1996-03-15 HU HU9801691A patent/HUP9801691A3/hu unknown
- 1996-03-15 JP JP8527295A patent/JPH11501649A/ja not_active Ceased
- 1996-03-15 PL PL96322202A patent/PL322202A1/xx unknown
- 1996-03-15 SK SK1239-97A patent/SK123997A3/sk unknown
- 1996-03-15 CZ CZ972896A patent/CZ289697A3/cs unknown
- 1996-03-15 NZ NZ304027A patent/NZ304027A/xx not_active IP Right Cessation
- 1996-03-15 CA CA002215382A patent/CA2215382A1/en not_active Abandoned
- 1996-03-17 IL IL11751696A patent/IL117516A/xx not_active IP Right Cessation
- 1996-03-18 ZA ZA962177A patent/ZA962177B/xx unknown
-
1997
- 1997-09-15 NO NO974255A patent/NO974255L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL117516A (en) | 2000-07-26 |
| NZ304027A (en) | 2000-05-26 |
| HUP9801691A3 (en) | 1999-03-01 |
| SK123997A3 (en) | 1998-02-04 |
| HUP9801691A2 (hu) | 1998-11-30 |
| ZA962177B (en) | 1996-07-29 |
| AR002283A1 (es) | 1998-03-11 |
| PL322202A1 (en) | 1998-01-19 |
| CZ289697A3 (en) | 1997-12-17 |
| DE19510861A1 (de) | 1996-09-19 |
| EP0814811A1 (de) | 1998-01-07 |
| NO974255L (no) | 1997-11-14 |
| KR19980703058A (ko) | 1998-09-05 |
| WO1996028165A1 (de) | 1996-09-19 |
| AU713258B2 (en) | 1999-11-25 |
| JPH11501649A (ja) | 1999-02-09 |
| NO974255D0 (no) | 1997-09-15 |
| CA2215382A1 (en) | 1996-09-19 |
| AU5110896A (en) | 1996-10-02 |
| IL117516A0 (en) | 1996-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ234051A (en) | Treating post-menopausal disorders using an estrogenic compound mixed with a compound having progestational activity | |
| DE69710896D1 (en) | Progestogen-anti-progestogen therapien | |
| PL327182A1 (en) | Method of preventing conception among female mammals through combined application of gestagen and oestrogen and combination of active agent therefor | |
| IL122109A0 (en) | A two-stage pharmaceutical preparation for hormonal contraception and a kit containing the same | |
| BG101553A (en) | Progesterone antagonist and antiestrogenous active compounds of general application for female contraceptives | |
| UA41401C2 (uk) | Фармацевтичний контрацептивний комбінований препарат | |
| UA48973C2 (uk) | Трансдермальний пластир на основі 17-деацетилноргестимату для попередження овуляції | |
| EP1319404A3 (de) | Mittel zur Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen | |
| GR970100477A (el) | Νεα συνθεση | |
| BG104451A (en) | Antiestrogen and progestin-containing peroral contraceptives | |
| BG101349A (en) | Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy | |
| LU90341I2 (fr) | 75 Ug de désogestrel en l'absence éthinyl oestradiol (cerazette) | |
| WO1994002103A3 (de) | Ovulationshemmendes mittel zur hormonalen kontrazeption | |
| MX9707009A (es) | Inyeccion de una vez al mes como un contraceptivo de base y para terapia de reemplazamiento hormonal para mujeres perimenopausicas y premenopausicas. | |
| UA41351C2 (uk) | Спосіб контрацепції та набір таблеток | |
| HUP9903097A2 (hu) | Progesztogén-antiprogesztogén tartalmú gyógyszerkészítmény |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| GD | Licence granted | ||
| HC | Change of company name or juridical status |
Owner name: PFIZER IRELAND PHARMACEUTICALS |
|
| MM | Annulment or lapse due to non-payment of fees |